Low-Value Prostate-Specific Antigen Screening in Older Males.

ABSTRACT:

Importance

The US Preventive Services Task Force guidelines advise against prostate-specific antigen (PSA) screening for prostate cancer in males older than 69 years due to the risk of false-positive results and overdiagnosis of indolent disease. However, this low-value PSA screening in males aged 70 years or older remains common.

Objective

To characterize the factors associated with low-value PSA screening in males 70 years or older.

Design, setting, and participants

This survey study used data from the 2020 Behavioral Risk Factor Surveillance System (BRFSS), a nationwide annual survey conducted by the Centers for Disease Control and Prevention that collects information via telephone from more than 400 000 US adults on behavioral risk factors, chronic illnesses, and

SUBMITTER: Kalavacherla S 

PROVIDER: S-EPMC10091155 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature